NSCLC Treatment Paradigm: Where Do We Stand?
NSCLC Treatment Paradigm: Where Do We Stand? NSCLC treatment paradigm: where do we stand? Lung cancer is, by a large margin, the leading cause [...]
12
06, 2018
Recent AML Launches – What Have We Learned?
Recent Launches for Acute Myeloid Leukemia (AML) What We’ve Learned Advancements in medicine have equipped physicians to assign distinct prognostic groups to patients with AML [...]
8
06, 2018
Medimix Launches Real World Cancer Support Program
Medimix International today announced that it has launched a campaign to support cancer research by proposing to the members of its global HCP community to match dollar for dollar the portion of their honoraria they would donate for research against cancer. The first donations will go to the Cancer Research Institute, one of the highest ranked charities for cancer research.
21
05, 2018
Medimix Featured in Pharma Tech Outlook as Among Top 10 Analytics Solution for the Pharmaceutical Industry
Medimix International Featured in Pharma Tech Outlook as Among Top 10 Analytics Solution for the Pharmaceutical industry Medimix was selected for the development of its innovative, cloud-based [...]
18
01, 2018
Proud to announce a new addition to our executive team.
Proud to announce Philippe Capart to our executive team Medimix International is proud to announce a new addition to its executive team. Philippe [...]
